Minimally Invasive Surgery Techniques for One-level Degenerative Lumbar Deformities Correction
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03908203 |
|
Recruitment Status :
Withdrawn
(The Study will be conducted in another research center. The Sponsor has changed.)
First Posted : April 9, 2019
Last Update Posted : September 11, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This study will be conducted at Research Institute of Traumatology and Orthopedics (NRITO) n.a. Ya.L.Tsivyan, Novosibirsk, Russia.
The current study is prospective pilot clinical study to demonstrate the possibility and effectiveness of performing modified technique of MIS TLIF, supplemented by segmental vertebrotomy, to correct segmental deformity of lumbar spine.
It is expected to enroll 10 patients aged 18-70 with segmental deformity of lumbar spine, caused by degenerative spondylolisthesis and/or degenerative stenosis.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Intervertebral Disc Degeneration Spinal Fusion | Procedure: Minimally invasive one-level lumbar deformity correction | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 0 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Minimally Invasive Surgery Techniques for One-level Degenerative Lumbar Deformities Correction |
| Estimated Study Start Date : | October 1, 2020 |
| Estimated Primary Completion Date : | April 1, 2021 |
| Estimated Study Completion Date : | April 1, 2022 |
| Arm | Intervention/treatment |
|---|---|
| Treatment Arm |
Procedure: Minimally invasive one-level lumbar deformity correction
The study treatment represents modified technique of MIS TLIF: one level screws fixation using Wiltse approach at one side, the other side - percutaneously, one level decompression, correction of segmental deformity by performing vertebrotomy and then intervertebral fusion. |
- Angle change at lumbar spine segment [ Time Frame: At 1 Day of hospital discharge or 14th day of hospital stay (depends on what event comes first) ]Angle between endplates at the treated level of lumbar spine
- Improvement of Visual analog scale (VAS) back pain intensity [ Time Frame: 3, 6, 12 months ]
To observe the improvement of VAS back pain as compared to baseline through follow-up terms.
Visual Analogue Scale (VAS) - patient-reported pain intensity (0 - no pain, 10 - unbearable pain).
- Improvement of Visual analog scale (VAS) leg pain intensity [ Time Frame: 3, 6, 12 months ]
To observe the improvement of VAS leg pain as compared to baseline through follow-up terms.
Visual Analogue Scale (VAS) - patient-reported pain intensity (0 - no pain, 10 - unbearable pain).
- Improvement of Oswestry Disability Index (ODI) [ Time Frame: 3, 6, 12 months ]To observe the improvement of ODI as compared to baseline through follow-up terms Oswestry Disability Index - patient-reported physical and household activity. Minimum - 0 % (the best result, the patient has no limitations in physical activity). Maximum - 100% (the worst result, patient is not physically active at all).
- Fusion rate success [ Time Frame: 12 months ]
To observe the Fusion rate (I, II, III or IV grade according to Tan).
Grade I - complete fusion; Grade II - partial fusion; Grade III - unipolar pseudarthrosis; Grade IV - bipolar pseudarthrosis.
- Range of Motion [ Time Frame: At 1 Day of hospital discharge or 14th day of hospital stay depends on what event comes first, 12 months ]To observe the disc mobility at the treated level
- Sagittal balance parameters [ Time Frame: At 1 Day of hospital discharge or 14th day of hospital stay depends on what event comes first, 12 months ]To observe sagittal balance as compared to baseline
- Disc height [ Time Frame: At 1 Day of hospital discharge or 14th day of hospital stay depends on what event comes first, 12 months ]To observe disc height at the treated level as compared to baseline
- Blood loss [ Time Frame: Day of surgery ]Blood loss
- Surgery duration [ Time Frame: Day of surgery ]Surgery duration
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Given written Informed Consent;
- Single-level segmental deformity caused by degenerative spondylolisthesis and/or degenerative stenosis at the one level of lumbar spine L4-L5 or L5-S1;
- Mono- and/or polyradicular leg pain and/or neurogenic claudication with or without back pain;
- Symptoms persisting for at least three months prior to surgery;
- Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements.
Exclusion Criteria:
- Lumbar deformation of non-degenerative etiology;
- Spondylolisthesis grade II or higher (25% slip or greater) of any etiology;
- Patient that has already undergone a lumbar fusion surgery;
- Other non-degenerative spinal conditions (e.g. infectious, traumatic, metabolic, inflammatory, neoplastic, structural or other pathology) that may have an impact on subject safety, wellbeing or the intent and conduct of the study
- Concurrent participation in another clinical study that may confound study results.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03908203
| Russian Federation | |
| Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan | |
| Novosibirsk, Russian Federation, 630091 | |
| Principal Investigator: | Aleksandr V Krutko, PhD, MD | Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan |
| Responsible Party: | Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan |
| ClinicalTrials.gov Identifier: | NCT03908203 |
| Other Study ID Numbers: |
NS02-02 |
| First Posted: | April 9, 2019 Key Record Dates |
| Last Update Posted: | September 11, 2020 |
| Last Verified: | February 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Intervertebral Disc Degeneration Spinal Diseases Bone Diseases Musculoskeletal Diseases |

